Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential data.
This move was revealed following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesman later explained that the US was seeking health data for research and commercial purposes while was unwilling to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more talks to find a deal suitable to all parties so the nation's vital HIV programme can proceed.
Wider Background
This rejection follows a similar situation in Kenya, where a court halted a related health funding agreement after concerns were raised about the security of citizens' medical information.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date signed these new agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no equivalent promise of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would provide the basic resources for medical research without any assurance that the end products would be accessible to our population if a new disease outbreak arise."
National Interest and Global Health
Mangwana further said that the American exit from the global health body and its push of bilateral deals were undermining systems already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage future pandemics.
"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations need to persist considering a large portion of the nation's HIV programmes depended on foreign aid.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it added.
The halted deal underscores the ongoing debate between accepting much-needed international aid and protecting a country's data in an increasingly data-driven world.